Predicting pacemaker implantation in cardiac amyloidosis: let's start with an ECG

Fernando Dominguez^{1

2}

Affiliations

¹ Heart Failure and Inherited Cardiac Diseases Unit, Department of Cardiology, Hospital Universitario Puerta de Hierro Madrid, Madrid, Spain.
² Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

Free article

Editorial

Fernando Dominguez. Eur J Heart Fail. 2022 Jul.

Free article

. 2022 Jul;24(7):1237-1238.

doi: 10.1002/ejhf.2591. Epub 2022 Jul 5.

Fernando Dominguez^{1

2}

¹ Heart Failure and Inherited Cardiac Diseases Unit, Department of Cardiology, Hospital Universitario Puerta de Hierro Madrid, Madrid, Spain.
² Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

No abstract available

Comment on

Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis.
Porcari A, Rossi M, Cappelli F, Canepa M, Musumeci B, Cipriani A, Tini G, Barbati G, Varrà GG, Morelli C, Fumagalli C, Zampieri M, Argirò A, Vianello PF, Sessarego E, Russo D, Sinigiani G, De Michieli L, Di Bella G, Autore C, Perfetto F, Rapezzi C, Sinagra G, Merlo M. Porcari A, et al. Eur J Heart Fail. 2022 Jul;24(7):1227-1236. doi: 10.1002/ejhf.2533. Epub 2022 May 16. Eur J Heart Fail. 2022. PMID: 35509181

1. Bianchi G, Zhang Y, Comenzo RL. AL amyloidosis: current chemotherapy and immune therapy treatment strategies: JACC: CardioOncology state-of-the-art review. JACC CardioOncol. 2021;3:467-87.
1. Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, et al.; ATTR-ACT Study Investigators. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med. 2018;379:1007-16.
1. Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, et al. Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur J Heart Fail. 2021;23:512-26.
1. Ridolfi RL, Bulkley BH, Hutchins GM. The conduction system in cardiac amyloidosis. Clinical and pathologic features of 23 patients. Am J Med. 1977;62:677-86.
1. Frustaci A, Letizia C, Adamo F, Grande C, Verardo R, Chimenti C. A-V block as presentation of cardiac amyloid: prominent infiltration of conduction tissue revealed by endomyocardial biopsy. Amyloid Int J Exp Clin Investig. 2017;24:131-2.